Page last updated: 2024-10-25

cycloleucine and Akinetic-Rigid Variant of Huntington Disease

cycloleucine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies

Cycloleucine: An amino acid formed by cyclization of leucine. It has cytostatic, immunosuppressive and antineoplastic activities.
1-aminocyclopentanecarboxylic acid : A non-proteinogenic alpha-amino acid that is cyclopentane substituted at position 1 by amino and carboxy groups.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Canals, JM1
Marco, S1
Checa, N1
Michels, A1
PĂ©rez-Navarro, E1
Arenas, E1
Alberch, J1

Other Studies

1 other study available for cycloleucine and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 after excitotoxicity in a rat model of Huntington's disease.
    Neurobiology of disease, 1998, Volume: 5, Issue:5

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Brain-Derived Neurotrophic Factor

1998